Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | CHEK2 |
Variant | D82_E86del |
Impact List | deletion |
Protein Effect | loss of function - predicted |
Gene Variant Descriptions | CHEK2 D82_E86del results in the deletion of five amino acids in the Chek2 protein from amino acid 82 to 86 (UniProt.org). D82_E86del (reported as P75_E79del) results in decreased Chek2 kinase activity in an in vitro assay (PMID: 17721994), and therefore, is predicted to lead to a loss of Chek2 protein function. |
Associated Drug Resistance | |
Category Variants Paths |
CHEK2 mutant CHEK2 inact mut CHEK2 D82_E86del |
Transcript | NM_007194.4 |
gDNA | chr22:g.28734485_28734499del15 |
cDNA | c.246_260del15 |
Protein | p.D82_E86delDQEPE |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
XM_011529839.3 | chr22:g.28734494_28734508del15 | c.244_258del15 | p.Y82_E86delYSIPE | RefSeq | GRCh38/hg38 |
XM_011529841.1 | chr22:g.28734485_28734499del15 | c.246_260del15 | p.D82_E86del | RefSeq | GRCh38/hg38 |
XM_011529845.3 | chr22:g.28699926_28703507del3582 | c.244_258del3582 | p.L82_G86delLMEGG | RefSeq | GRCh38/hg38 |
XM_011529842.3 | chr22:g.28734494_28734508del15 | c.244_258del15 | p.Y82_E86delYSIPE | RefSeq | GRCh38/hg38 |
NM_001349956.1 | chr22:g.28734485_28734499del15 | c.246_260del15 | p.D82_E86del | RefSeq | GRCh38/hg38 |
NM_145862.2 | chr22:g.28734485_28734499del15 | c.246_260del15 | p.D82_E86delDQEPE | RefSeq | GRCh38/hg38 |
NM_001005735.2 | chr22:g.28734485_28734499del15 | c.246_260del15 | p.D82_E86delDQEPE | RefSeq | GRCh38/hg38 |
NM_001005735.1 | chr22:g.28734485_28734499del15 | c.246_260del15 | p.D82_E86del | RefSeq | GRCh38/hg38 |
XM_011529844.3 | chr22:g.28734494_28734508del15 | c.244_258del15 | p.Y82_E86delYSIPE | RefSeq | GRCh38/hg38 |
XM_047441108.1 | chr22:g.28711964_28711978del15 | c.244_258del15 | p.T82_V86delTCKKV | RefSeq | GRCh38/hg38 |
XM_024452149.2 | chr22:g.28734494_28734508del15 | c.244_258del15 | p.Y82_E86delYSIPE | RefSeq | GRCh38/hg38 |
XM_047441104.1 | chr22:g.28734485_28734499del15 | c.246_260del15 | p.D82_E86delDQEPE | RefSeq | GRCh38/hg38 |
XM_047441106.1 | chr22:g.28734485_28734499del15 | c.246_260del15 | p.D82_E86delDQEPE | RefSeq | GRCh38/hg38 |
XM_006724114.4 | chr22:g.28711964_28711978del15 | c.244_258del15 | p.T82_V86delTCKKV | RefSeq | GRCh38/hg38 |
NM_001257387.2 | chr22:g.28699926_28703507del3582 | c.244_258del3582 | p.L82_G86delLMEGG | RefSeq | GRCh38/hg38 |
NM_001349956.2 | chr22:g.28734485_28734499del15 | c.246_260del15 | p.D82_E86delDQEPE | RefSeq | GRCh38/hg38 |
XM_011529840.4 | chr22:g.28734494_28734508del15 | c.244_258del15 | p.Y82_E86delYSIPE | RefSeq | GRCh38/hg38 |
XM_047441107.1 | chr22:g.28734494_28734508del15 | c.244_258del15 | p.Y82_E86delYSIPE | RefSeq | GRCh38/hg38 |
NM_007194.3 | chr22:g.28734485_28734499del15 | c.246_260del15 | p.D82_E86del | RefSeq | GRCh38/hg38 |
XM_017028560.2 | chr22:g.28734494_28734508del15 | c.244_258del15 | p.Y82_E86delYSIPE | RefSeq | GRCh38/hg38 |
NM_145862.2 | chr22:g.28734485_28734499del15 | c.246_260del15 | p.D82_E86del | RefSeq | GRCh38/hg38 |
XM_047441105.1 | chr22:g.28734485_28734499del15 | c.246_260del15 | p.D82_E86delDQEPE | RefSeq | GRCh38/hg38 |
NM_007194.4 | chr22:g.28734485_28734499del15 | c.246_260del15 | p.D82_E86delDQEPE | RefSeq | GRCh38/hg38 |
XM_024452148.2 | chr22:g.28734494_28734508del15 | c.244_258del15 | p.Y82_E86delYSIPE | RefSeq | GRCh38/hg38 |
XM_006724116.3 | chr22:g.28710051_28711914del1864 | c.244_258del1864 | p.E82_A86delEADPA | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|